Hypertension affects a substantial part of the world’s population. Treatment options include lifestyle changes and drug-based therapies. Device-based therapies for hypertension are under development and used within the context of clinical studies and randomized controlled and sham-controlled trials. Research on device-based therapies for hypertension typically use ambulatory blood pressure monitoring (ABPM) as primary endpoint. Key imaging modalities include Echocardiography, MRI and renal CTA.

dabl and Cardialysis have entered a partnership to combine specialized ABPM services with imaging and electrophysiological Core Lab techniques required in this field.